ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
化工社オープンプロジェクト:[email protected]AIアクセス:llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.7.8
  1. ホーム
  2. /化合物

1,2,3,4,6,7,8-Heptachlorodibenzofuran

HCID 38199
ノート反応
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
38998-75-3
標準SMILES
Clc1cc2c(oc3c(Cl)c(Cl)c(Cl)c(Cl)c32)c(Cl)c1Cl
InChIKey
WDMKCPIVJOGHBF-UHFFFAOYSA-N
分子式
C12HCl7O
平均分子量
409.3 g/mol
単同位体質量
405.784709

概要

1,2,3,4,6,7,8-Heptachlorodibenzofuran is a polychlorinated dibenzofuran.

名称と識別子

優先名称
1,2,3,4,6,7,8-Heptachlorodibenzofuran
IUPAC
1,2,3,4,6,7,8-heptachlorodibenzofuran
英語名
1,2,3,4,6,7,8-Heptachlorodibenzofuran
分子式
C12HCl7O
分子量
0

名称と別名

1,2,3,4,6,7,8-HEPTACHLORODIBENZOFURAN67562-39-41,2,3,4,6,7,8-HpCDFPCDF 13158J222A38NHCDBF cpdRefChem:4104673,4,5,6,10,11,12-heptachloro-8-oxatricyclo(7.4.0.02,7)trideca-1(13),2,4,6,9,11-hexaene694-815-4HEPTACHLORODIBENZOFURAN38998-75-3F 131
名称をさらに表示
Dibenzofuran, 1,2,3,4,6,7,8-heptachloro-67652-39-51,2,3,4,6,7,8-Heptachlorodibenzo[b,d]furanDibenzofuran, heptachloro-HeptachlorodibenzofuransC12HCl7OUNII-3852E118OUUNII-58J222A38N

データベース識別子

CAS
38998-75-3、67562-39-4、67652-39-5
PubChem CID
38199
DTXSID
DTXSID8052350
ChEBI
CHEBI:81513
UNII
58J222A38N
EC Number
694-815-4
Nikkaji
J401.107D

物性

構造計算による物性

XLogP
7.9
極性表面積
13.1 Ų
水素結合供与体数
0
水素結合受容体数
1
回転可能結合数
0
重原子数
20
形式電荷
0
複雑度
383

実験および物理化学的性質

PolymersOther Classes -> Halogenated Polyaromatics
SpringerMaterials PropertiesBoiling point
LogP7.92
Endocrine DisruptorsPotential endocrine disrupting compound
Collision Cross Section170.8 Ų [M]+ [CCS Type: TIMS, Method: calibration with PAHs]

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 4 件

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

P264, P264+P265, P270, P273, P280, P301+P316, P305+P351+P338, P321, P330, P337+P317, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 39 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Regulatory Information · 2 件

Hazard Traits - Bioaccumulation; Carcinogenicity; Dermatotoxicity; Developmental Toxicity; Endocrine Toxicity; Environmental Persistence; Environmental tox; Hematotoxicity; Hepatotoxicity and Digestive System Toxicity; Reproductive Toxicity

Regulation (EC) No 178/2002 (amended)

Hazards SummarySee CHLORINATED DIBENZOFURANS.
Hazard Classes and CategoriesAcute Tox. 3 (100%)

安全と保護具

Protective Action Criteria (PAC) · 3 件

0.013 [mg/m3]

0.14 [mg/m3]

0.85 [mg/m3]

毒性情報

Health Effects · 1 件

CDFs cause vomiting and diarrhea, anemia, more frequent lung infections, numbness and other effects on the nervous system, and mild changes in the liver. However, there were no permanent liver changes or definite liver damage found in people who ingested CDFs. (L952)

Adverse Effects

化学と産業

薬理情報

Metabolism/Metabolites · 1 件

No information on the metabolism of dibenzofuran in mammalian organisms was found in the available literature. The bacteria Sphingomonas, Brevibacterium, Terrabacter, and Staphylococcus auricularis degrade dibenzofuran to 2,2',3-trihydroxybiphenyl via dibenzofuran 4,4a-dioxygenase. (L952)

用途と製造

UsesCDFs are created from production of coal tar and during incineration. They are used as insecticides, in the production of PVC, and in industrial bleaching. (L952)

サプライヤー2 社

深圳聚合生化科技有限公司+86-400-002-6226 13028896684 · [email protected]
北京百灵威科技有限公司18210857532 18210857532 · [email protected]

関連反応

0 件
反応記録を作成

現在のフィルター条件では反応記録がありません。

化合物ノート

読み込み中…

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
Occupational hepatotoxin - Secondary hepatotoxins: the potential for toxic effect in the occupational setting is based on cases of poisoning by human ingestion or animal experimentation.
Exposure RoutesInhalation (L952) ; dermal (L952) ; oral (L952)
Toxicity Summary · 1 件

Halogenated dibenzofurans (PCDFs and PBDFs) bind the aryl hydrocarbon receptor (AhR), which increases its ability to activate transcription in the XRE (xenobiotic resoponse element) promoter region. Specifically AhR binds to the PCDF, translocates it to the nucleus and together with hydrocarbon nuclear translocator (ARNT) and xenobiotic responsive element (XRE) increases the expression of CYP1A1 and aryl hydrocarbon hydroxylase (CYP1B1). AhR signaling also increseases conversion of arachidonic acid to prostanoids via cyclooxygenase-2, alters Wnt/beta-catenin signaling downregulating Sox9 and alters signaling by receptors for inflammatory cytokines. AhR signalling also alters proteasomal degradation of steroid hormone receptors, alters cellular UVB stress response and changes the differentiation of certain T-cell subsets. The resulting AhR mediated activation and alteration leads to body weight loss, cancer and thymic atrophy (characteristic of immune and endocrine disruption) which are common toxic responses to PCDFs and related toxic halogenated aryl hydrocarbons.

Signs and SymptomsSkin and eye irritations, especially severe acne, darkened skin color, and swollen eyelids with discharge are the most obvious health effects of the CDF poisoning. (L952)
Carcinogen Classification3, not classifiable as to its carcinogenicity to humans. (L135)
RAIS Toxicity Values · 6 件

0.38

WHO/TEF

4e-06

WHO/TEF

7e-08

WHO/TEF